A detailed history of Wellington Management Group LLP transactions in Merus N.V. stock. As of the latest transaction made, Wellington Management Group LLP holds 2,887,514 shares of MRUS stock, worth $124 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,887,514
Previous 1,662,941 73.64%
Holding current value
$124 Million
Previous $98.4 Million 46.61%
% of portfolio
0.03%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$47.19 - $58.84 $57.8 Million - $72.1 Million
1,224,573 Added 73.64%
2,887,514 $144 Million
Q2 2024

Aug 13, 2024

BUY
$39.81 - $60.2 $16.5 Million - $24.9 Million
414,301 Added 33.18%
1,662,941 $98.4 Million
Q1 2024

May 15, 2024

BUY
$28.03 - $51.82 $35 Million - $64.7 Million
1,248,640 New
1,248,640 $56.2 Million
Q4 2023

Feb 12, 2024

BUY
$20.06 - $28.66 $40.3 Million - $57.6 Million
2,009,403 New
2,009,403 $55.3 Million
Q3 2023

Nov 14, 2023

BUY
$20.13 - $27.29 $1.21 Million - $1.64 Million
60,135 Added 2.25%
2,735,247 $64.5 Million
Q2 2023

Aug 14, 2023

SELL
$18.33 - $27.18 $8.47 Million - $12.6 Million
-462,133 Reduced 14.73%
2,675,112 $70.4 Million
Q1 2023

May 12, 2023

SELL
$14.25 - $20.5 $7.88 Million - $11.3 Million
-553,107 Reduced 14.99%
3,137,245 $57.7 Million
Q4 2022

Feb 13, 2023

BUY
$12.8 - $23.66 $22.4 Million - $41.5 Million
1,752,964 Added 90.48%
3,690,352 $57.1 Million
Q3 2022

Nov 14, 2022

BUY
$18.64 - $28.93 $3.14 Million - $4.87 Million
168,193 Added 9.51%
1,937,388 $38.8 Million
Q2 2022

Aug 15, 2022

SELL
$13.98 - $29.25 $16.6 Million - $34.8 Million
-1,189,077 Reduced 40.19%
1,769,195 $40.1 Million
Q1 2022

May 16, 2022

SELL
$23.58 - $30.91 $4.63 Million - $6.07 Million
-196,279 Reduced 6.22%
2,958,272 $78.2 Million
Q4 2021

Feb 11, 2022

SELL
$20.0 - $32.29 $37.1 Million - $59.9 Million
-1,854,653 Reduced 37.02%
3,154,551 $100 Million
Q3 2021

Nov 15, 2021

BUY
$16.48 - $27.23 $47.4 Million - $78.3 Million
2,876,971 Added 134.93%
5,009,204 $110 Million
Q2 2021

Aug 16, 2021

BUY
$20.0 - $25.48 $6.13 Million - $7.81 Million
306,330 Added 16.78%
2,132,233 $44.9 Million
Q1 2021

May 17, 2021

BUY
$16.14 - $29.11 $9.74 Million - $17.6 Million
603,185 Added 49.33%
1,825,903 $38.1 Million
Q4 2020

Feb 12, 2021

BUY
$11.4 - $18.36 $5.46 Million - $8.79 Million
478,927 Added 64.39%
1,222,718 $21.4 Million
Q3 2020

Nov 16, 2020

SELL
$10.57 - $16.0 $100,552 - $152,208
-9,513 Reduced 1.26%
743,791 $8.93 Million
Q2 2020

Aug 14, 2020

SELL
$10.5 - $17.36 $946,879 - $1.57 Million
-90,179 Reduced 10.69%
753,304 $12.1 Million
Q1 2020

May 14, 2020

SELL
$11.34 - $19.44 $785,578 - $1.35 Million
-69,275 Reduced 7.59%
843,483 $10.2 Million
Q4 2019

Feb 11, 2020

BUY
$14.08 - $18.5 $12.9 Million - $16.9 Million
912,758 New
912,758 $12.9 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.96B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.